MSSA (Methicillin- Susceptible Staphylococcus Aureus)
Showing 1 - 25 of 1,620
Bacteremia Due to Methicillin Susceptible Staphylococcus Aureus Trial in Paris (Cloxacillin, Cefazolin)
Recruiting
- Bacteremia Due to Methicillin Susceptible Staphylococcus Aureus
-
Paris, FranceFrançois-Xavier Lescure
Dec 7, 2022
Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Septicemia, Staphylococcal Sepsis Trial in Montreal (Ertapenem, Placebo)
Not yet recruiting
- Staphylococcus Aureus Bacteremia
- +3 more
- Ertapenem
- Placebo
-
Montreal, Quebec, CanadaMcGill University Health Centre (Royal Victoria Hospital and Mon
Feb 21, 2022
Antistaphylococcal Betalactam and Emergence of Resistance
Completed
- Bacterial Resistance
- Methicillin-Sensitive Staphylococcus Aureus Infection
-
Nancy, Lorraine, FranceLefevre
Jul 1, 2023
Diabetic Foot, Staphylococcal Infections Trial in France (Topical anti-Staphylococcus bacteriophage therapy, Topical
Not yet recruiting
- Diabetic Foot
- Staphylococcal Infections
- Topical anti-Staphylococcus bacteriophage therapy
- Topical placebo corresponding to anti-Staphylococcus bacteriophage therapy
-
Bordeaux, France
- +8 more
Feb 2, 2022
Hemodialysis Catheter Infection, Infection, Bacterial Trial in Orléans, Tours (Blood samples)
Not yet recruiting
- Hemodialysis Catheter Infection
- Infection, Bacterial
- Blood samples
-
Orléans, France
- +1 more
Oct 16, 2023
Bacteremia Due to Staphylococcus Aureus, Left Sided Infective Endocarditis (Disorder), Right Sided Infective Endocarditis
Withdrawn
- Bacteremia Due to Staphylococcus Aureus
- +3 more
- Tonabacase (LSVT-1701)
-
Butte, MontanaLsvt-1701-2001
Jun 27, 2022
Initial and Chronic Methicillin Resistant Staphylococcus Aureus
Completed
- Methicillin-Resistant Staphylococcus Aureus
- Cystic Fibrosis
- Intervention N/A. Observational study
-
Birmingham, Alabama
- +2 more
Jan 19, 2022
MRSA Bloodstream Infection, MRSA Bacteremia, MRSA Right-sided Endocarditis Trial in Butte, Toledo (Exebacase)
No longer available
- MRSA Bloodstream Infection
- +3 more
-
Butte, Montana
- +1 more
Aug 25, 2022
Methicillin Susceptible Staphylococcus Aureus Septicemia, Bacteremia Trial in Montreal (Daptomycin, Placebo)
Completed
- Methicillin Susceptible Staphylococcus Aureus Septicemia
- Bacteremia
- Daptomycin
- Placebo
-
Montreal, Quebec, CanadaMcGill University Health Centre (Royal Victoria Hospital, Montre
Sep 18, 2020
Methicillin-Resistant Staphylococcus Aureus, Bacterial Infections, Staphylococcal Skin Infections Trial in Worldwide
Recruiting
- Methicillin-Resistant Staphylococcus Aureus
- +2 more
- Dalbavancin single dose
- +2 more
-
Mobile, Alabama
- +26 more
Jan 27, 2023
Probability of Target Attainment With Standard Intermittent
Completed
- Staphylococcus Aureus Infection
- Blood samples for the measurement of the concentration of cefazolin
- +4 more
-
Basel, SwitzerlandUniversity Hospital Basel, Division of Internal Medicine
Mar 28, 2022
Methicillin-resistant Staphylococcus Aureus Infection Trial in Falls Church, Leesburg (Preoperative MRSA screening)
Terminated
- Methicillin-resistant Staphylococcus Aureus Infection
- Preoperative MRSA screening
-
Falls Church, Virginia
- +1 more
Jun 3, 2021
Staphylococcus Aureus Bacteremia Trial in Worldwide (Cefazolin, Penicillin, Clindamycin)
Recruiting
- Staphylococcus Aureus Bacteremia
- Cefazolin
- +4 more
-
Garran, Australia Capital Territory, Australia
- +73 more
Feb 23, 2022
Multidrug Resistant Bacterial Infection, Enterobacteriaceae Infections, Pseudomonas Aeruginosa Trial in Philadelphia (PMT)
Not yet recruiting
- Multidrug Resistant Bacterial Infection
- +4 more
-
Philadelphia, PennsylvaniaHospital of the University of Pennsylvania
Nov 17, 2022
Antibiotic Prophylaxis, General Surgery Trial in Marseille (Vancomycin Injection, Linezolid Injection)
Not yet recruiting
- Antibiotic Prophylaxis
- General Surgery
- Vancomycin Injection
- Linezolid Injection
-
Marseille, FranceAnesthésie Réanimation - Hôpital Nord (AP-HM)
Oct 5, 2022
Healthy Volunteers, Anti-Bacterial Agents, Methicillin-Resistant Staphylococcus Aureus Trial in Seoul (N-Rephasin® SAL200,
Completed
- Healthy Volunteers
- +3 more
- N-Rephasin® SAL200
- INT200-Placebo
-
Seoul, Korea, Republic ofSeoul National University Hospital
Oct 26, 2021
Emergencies Trial (GeneXpert®)
Withdrawn
- Emergencies
- GeneXpert®
- (no location specified)
Nov 9, 2020
CA-MRSA Transmission: An ED Population Sampling Strategy
Recruiting
- Methicillin-Resistant Staphylococcus Aureus
- Acute Abscess Group
-
Gainesville, FloridaUF Health
Jun 4, 2021
Staphylococcus Aureus Bacteremia, Anti-Bacterial Agents Trial in Seongnam-si, Seoul (N-Rephasin® SAL200, Placebo)
Terminated
- Staphylococcus Aureus Bacteremia
- Anti-Bacterial Agents
- N-Rephasin® SAL200
- Placebo
-
Seongnam-si, Gyeonggi-do, Korea, Republic of
- +1 more
Sep 12, 2021
Cystic Fibrosis, Methicillin-resistant Staphylococcus Aureus Trial in Cleveland (Vancomycin)
Withdrawn
- Cystic Fibrosis
- Methicillin-resistant Staphylococcus Aureus
-
Cleveland, OhioRainbow Babies and Children's Hospital, Univeristy Hospitals Cas
Dec 23, 2021
Bone or Joint Infection Trial in Ukraine, United States (Afabicin (Part A), Standard of Care, Afabicin (Part B))
Recruiting
- Bone or Joint Infection
- Afabicin (Part A)
- +2 more
-
Sacramento, California
- +13 more
Sep 29, 2022
Staphylococcus Aureus, Carbapenem Resistant Gram Negative Bacteria Trial (Targeted gown and gloves use)
Not yet recruiting
- Staphylococcus Aureus
- Carbapenem Resistant Gram Negative Bacteria
- Targeted gown and gloves use
- (no location specified)
Oct 26, 2021
Infection Control Trial in Baltimore (Enhanced cleaning of surfaces in ICU rooms, Sham enhanced cleaning of surfaces in ICU
Completed
- Infection Control
- Enhanced cleaning of surfaces in ICU rooms
- Sham enhanced cleaning of surfaces in ICU rooms
-
Baltimore, MarylandUniversity of Maryland, Baltimore
Feb 15, 2022
Infection Control to Knee Periprosthetic Joint Infection -United
Recruiting
- Knee; Infection, Joint
- Two-stage exchange arthroplasty
-
Taoyuan, TaiwanDepartment of Orthopedic Surgery at Linkou Changgung Memorial Ho
Sep 11, 2023
Patients Undergoing Elective TJA: Benefits of Next-generation
Unknown status
- Staphylococcus Aureus
- +2 more
- next generation sequencing
-
Philadelphia, PennsylvaniaRothman Orthopaedic Institute
Sep 29, 2020